A detailed history of Driehaus Capital Management LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 106,815 shares of VERA stock, worth $4.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
106,815
Previous 255,133 58.13%
Holding current value
$4.7 Million
Previous $9.23 Million 48.86%
% of portfolio
0.05%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$34.09 - $46.71 $5.06 Million - $6.93 Million
-148,318 Reduced 58.13%
106,815 $4.72 Million
Q2 2024

Aug 14, 2024

SELL
$33.72 - $48.82 $71,621 - $103,693
-2,124 Reduced 0.83%
255,133 $9.23 Million
Q1 2024

May 15, 2024

BUY
$14.91 - $49.14 $2.82 Million - $9.29 Million
188,951 Added 276.62%
257,257 $11.1 Million
Q2 2023

Aug 14, 2023

BUY
$6.11 - $17.83 $417,349 - $1.22 Million
68,306 New
68,306 $1.1 Million

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.19B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.